NCT02212262View on ClinicalTrials.gov

Role of Osteocytes in Myeloma Bone Disease

CompletedOBSERVATIONAL
Enrollment

67

Participants

Timeline

Start Date

October 7, 2014

Primary Completion Date

February 5, 2022

Study Completion Date

February 5, 2022

Conditions
Multiple Myeloma
Trial Locations (2)

46202

Indiana University Simon Cancer Center, Indianapolis

VA Roudebush Medical Center, Indianapolis

All Listed Sponsors
lead

Attaya Suvannasankha

OTHER

NCT02212262 - Role of Osteocytes in Myeloma Bone Disease | Biotech Hunter | Biotech Hunter